Aspiriant LLC’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.09M Buy
39,802
+3,733
+10% +$800K 0.22% 51
2026
Q2
$7.22M Sell
36,069
-11,515
-24% -$2.37M 0.18% 61
2026
Q1
$8.3M Sell
47,584
-2,272
-5% -$417K 0.24% 50
2025
Q4
$9.3M Buy
49,856
+25,314
+103% +$4.71M 0.27% 47
2025
Q3
$4.58M Sell
24,542
-1,296
-5% -$226K 0.14% 67
2025
Q2
$4.08M Buy
25,838
+30
+0.1% +$3.78K 0.13% 75
2025
Q1
$2.8M Buy
25,808
+2,332
+10% +$296K 0.1% 80
2024
Q4
$3.15M Buy
23,476
+1,518
+7% +$209K 0.11% 76
2024
Q3
$2.67M Buy
21,958
+2,523
+13% +$298K 0.1% 83
2024
Q2
$2.4M Sell
19,435
-5,905
-23% -$597K 0.1% 85
2024
Q1
$2.29M Buy
25,340
+2,670
+12% +$194K 0.09% 93
2023
Q4
$1.12M Buy
22,670
+2,470
+12% +$114K 0.05% 137
2023
Q3
$879K Buy
20,200
+2,480
+14% +$111K 0.05% 143
2023
Q2
$750K Sell
17,720
-1,950
-10% -$64.7K 0.04% 150
2023
Q1
$546K Buy
19,670
+1,430
+8% +$30.9K 0.03% 169
2022
Q4
$267K Sell
18,240
-12,140
-40% -$178K 0.01% 228
2022
Q3
$369K Buy
30,380
+790
+3% +$12.5K 0.02% 189
2022
Q2
$448K Buy
29,590
+11,840
+67% +$223K 0.02% 172
2022
Q1
$486K Sell
17,750
-480
-3% -$12K 0.03% 176
2021
Q4
$537K Buy
18,230
+3,540
+24% +$97.4K 0.03% 174
2021
Q3
$304K Buy
14,690
+3,890
+36% +$80.8K 0.02% 196
2021
Q2
$216K Buy
+10,800
New +$173K 0.01% 225
2017
Q3
– Sell
-70,920
Closed -$256K – 214
2017
Q2
$256K Buy
+70,920
New +$225K 0.02% 186

Other funds holding NVDA

Aspiriant LLC's NVDA Position: Q3 2026 in Review

Aspiriant LLC increased its NVIDIA (NVDA) stake by 10% in Q3 2026, buying an estimated $800K and bringing the position to 39,802 shares worth $9.09M. The position accounts for 0.22% of the portfolio, ranked #51.

Aspiriant LLC first reported a position in NVDA in Q2 2017 and has held it in 23 quarters since. The position peaked at $9.3M in Q4 2025. 2,709 funds tracked by Wall St. Rank hold NVDA as of Q3 2026.

  • Aspiriant LLC held 39,802 shares of NVIDIA worth $9.09M as of Q3 2026.
  • Aspiriant LLC bought 3,733 NVIDIA shares in Q3 2026, an estimated $800K.
  • NVIDIA made up 0.22% of Aspiriant LLC's portfolio in Q3 2026, its #51 holding.
  • Aspiriant LLC first reported a position in NVIDIA in Q2 2017 and has held it in 23 quarters since.
  • Aspiriant LLC's NVIDIA position peaked at $9.3M in Q4 2025.
  • 2,709 funds tracked by Wall St. Rank held NVIDIA as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.